Digital Nerve Injury
0
Pipeline Programs
4
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Checkpoint TherapeuticsMA - Waltham
1 programBrief Electrical Stimulation TherapyN/A1 trial
Active Trials
Integra LifeSciencesAustralia - Clayton
1 programNeuraGen 3D Nerve Guide MatrixN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2022
2023
2024
2025
2026
2027
Checkpoint TherapeuticsBrief Electrical Stimulation Therapy
TissiumTISSIUM™ Nerve Coaptation Device
Integra LifeSciencesNeuraGen 3D Nerve Guide Matrix
Clinical Trials (3)
Total enrollment: 73 patients across 3 trials
Evaluating Therapeutic Electrical Stimulation to Improve Nerve Healing After Surgical Repair of Digital Nerve Injuries
Start: Apr 2025Est. completion: Mar 202760 patients
N/ARecruiting
TISSIUM's Nerve Coaptation Device First-in-Human Clinical Trial
Start: Dec 2022Est. completion: Sep 202412 patients
N/ACompleted
NeuraGen 3D Pilot Study
Start: May 2022Est. completion: May 20241 patients
N/ATerminated
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 73 patients
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.